ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2020 American Transplant Congress

    Outcomes of Induction with T Lymphocyte-Depleting and IL-2 Receptor Blocking (IL-2RB) Antibodies in the Non-Broadly Sensitized Adult Deceased-Donor Kidney Transplant Recipients: Analysis in the Context of the CPRA Allocation System

    A. H. Santos Jr1, Y. Li2, K. Alquadan1, M. Leghrouz1, X. Wen3

    1Div. of Nephrology, Univ. of Florida, Gainesville, FL, 2Univ. of Florida, Gainesville, FL, 3Univ. of Rhode Island, Kingston, RI

    *Purpose: We studied outcomes of induction in non-broadly-sensitized adult deceased-donor kidney transplant recipients(DD-KTRs) in the context of the calculated panel reactive antibody (CPRA) allocation system.*Methods:…
  • 2020 American Transplant Congress

    Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation

    V. Liu, M. W. Soto-Arenall, A. Patel

    Pharmacy, Mayo Clinic, Jacksonville, FL

    *Purpose: To identify the short-term efficacy and safety outcomes of alemtuzumab (C1H) versus rabbit antithymocyte globulin (rATG) in lung transplant patients. The objectives are to…
  • 2020 American Transplant Congress

    Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients

    T. Shaker1, K. Ramanathan1, S. Riad2, D. Vock3, S. Chinnakotla1

    1Surgery, Division of Transplantation, University of Minnesota, Minneapolis, MN, 2Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, 3Biostatistics, University of Minnesota, Minneapolis, MN

    *Purpose: Induction immunosuppression for pediatric liver transplants varies widely among centers. We sought to evaluate the impact of different induction regimens on patient and graft…
  • 2020 American Transplant Congress

    Outcomes of Intra-Operative Steroid Induction in Liver Transplant Recipients

    A. Poparad-Stezar, A. Jantz, T. Larson, B. Summers, N. Sulejmani

    Henry Ford Hospital, Detroit, MI

    *Purpose: Evidence supporting the use of antibody induction (AI) immunosuppression (IS) (antithymocyteglobulin (rATG) and basiliximab (BAS)) for acute rejection (AR) prophylaxis in liver transplant is…
  • 2020 American Transplant Congress

    Depletional Profiles of Human and Rhesus Specific Anti-Thymocyte Globulins in Rhesus Macaques

    B. I. Shaw1, R. Schmitz1, D. M. Magnani2, F. Leopardi1, A. D. Kirk1

    1Surgery, Duke University, Durham, NC, 2Medicine, MassBiologics of the University of Massachusetts Medical School, Boston, MA

    *Purpose: Rabbit anti-human ATG (rATG; Thymoglobulin®) is the most commonly used formulation for depletional induction therapy in the United States. However, given that it is…
  • 2020 American Transplant Congress

    Outcome of Induction Therapies in Low Sensitized Renal Transplant Recipients with Two HLA DR Mismatch in Tacrolimus Era

    K. Soliman1, T. Fulop1, A. Osman2, H. Ali3

    1Medicine, Medical University of South Carolina, Charleston, SC, 2Medicine, Cairo University, Cairo, Egypt, 3Medicine, Royal Stoke, Royal Stoke, United Kingdom

    *Purpose: A mismatch for two HLA DR antigens portends high immunological risk in renal transplant recipients (RTRs). Induction therapies with both rabbit Anti-thymocyte Globulin (r-ATG)…
  • 2020 American Transplant Congress

    Differences in Immunosuppressive Therapy among Liver Retransplantation Recipients in a National Cohort

    A. K. Mezochow, P. L. Abt, T. Bittermann

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT). This study explored: (i) factors associated with induction…
  • 2020 American Transplant Congress

    Effect of Rituximab Dose as Induction Therapy in ABO Incompatible Living Kidney Transplantation A Systemic Review and Network Meta Analysis

    S. Hwang1, W. Park2, K. Kim1, S. Lee1, J. Song1

    1Inha University, Incheon, Korea, Republic of, 2Keimyung University, Daegu, Korea, Republic of

    *Purpose: ABO-incompatible living kidney transplantation (ABOILKT) has steadily become more widespread. However, the optimal immunosuppressive regimen for ABOILKT remains uncertain. We aimed to determine the…
  • 2020 American Transplant Congress

    Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, 2Pharmacy, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: We have previously reported that favorable short-term outcomes of kidney recipients were achieved by corticosteroid early withdrawal protocol (CSEW) compared to the conventional protocol…
  • 2020 American Transplant Congress

    Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction

    H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler

    Hartford Hospital, Hartford, CT

    *Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences